Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myoma × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 28 Neoplasm Metastasis 15 Liver Neoplasms 14 Colorectal Neoplasms 11 Cholangiocarcinoma 9 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Pancreatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Barrett Esophagus 6 Recurrence 5 Thyroid Nodule 4 Thyroid Neoplasms 4 Rectal Neoplasms 4 Pain 4 Neoplasms 4 Carcinoma, Renal Cell 4 Kidney Neoplasms 3 Esophageal Neoplasms 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Hyperaldosteronism 2 Cancer Pain 2 Biliary Tract Neoplasms 2 Agnosia 2 Uterine Cervical Neoplasms 1 Thymoma 1 Squamous Intraepithelial Lesions 1

Interventions

Uterine Myomectomy 3 Uterine Artery Embolization 3 Sodium Chloride 3 Terlipressin 2 testo 1 carbetocin 1 Vasopressins 1 Tourniquets 1 Saline Solution 1 Radiofrequency Ablation 1 Oxytocin 1 Ofloxacin 1 MoxDuo 1 Misoprostol 1 Magnesium Sulfate 1 Hysteroscopy 1 Ethamsylate 1 Doxycycline 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡